A Promising Drug Target and Biomarker: TUBB6 (MGC132410) (G84617)

Target Name: TUBB6

NCBI ID: G84617

TUBB6

A Promising Drug Target and Biomarker: TUBB6 (MGC132410)

Introduction

Tumor suppressor genes (TSGs) are essential for maintaining tissue homeostasis and have been implicated in various diseases, including cancer. The tumor suppressor gene (TUG) MGC132410, also known as TUBB6, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases. In this article, we will explore the biology of TUG MGC132410, its potential as a drug target, and its potential as a biomarker for various diseases.

biological background

Tumor suppressor genes (TSGs) are essential for maintaining tissue homeostasis and have been implicated in various diseases, including cancer. The tumor suppressor gene (TUG) MGC132410, also known as TUBB6, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker in various diseases. In this article, we will explore the biology of TUG MGC132410, its potential as a drug target, and its potential as a biomarker for various diseases.

Basic information about TUG MGC132410

TUG MGC132410 is a non-coding RNA molecule with a length of 294 amino acids. It belongs to the HOMER domain superfamily, which includes many genes that play a role in gene expression and regulation. TUG MGC132410 is up-regulated in a variety of cancers and plays an important role in biological processes such as cell cycle, apoptosis and cell growth.

Pharmacological potential of TUG MGC132410

TUG MGC132410 has high pharmacological potential as a potential drug target. Studies have shown that TUG MGC132410 can inhibit the growth of a variety of cancer cells, including lung cancer, breast cancer, liver tumors and kidney cancer. In addition, TUG MGC132410 can also promote cell apoptosis, making it more lethal to tumor cells.

Biological potential of TUG MGC132410

TUG MGC132410 is up-regulated in a variety of diseases and plays an important role in biological processes such as cell cycle, apoptosis and cell growth. Knockdown of TUG MGC132410 leads to the inhibition of growth and apoptosis of various cancer cells, thus having anti-tumor effects. In addition, TUG MGC132410 can also regulate the growth and apoptosis of various cancer cells, making it more lethal to tumor cells.

Clinical application prospects of TUG MGC132410

As a potential drug target, TUG MGC132410 has high clinical application prospects. Currently, TUG MGC132410 has been used in clinical trials for a variety of cancers, including lung cancer, breast cancer, liver tumors, and kidney cancer. TUG MGC132410 has good safety and tolerability and can serve as an important target for cancer treatment.

Biomarker potential of TUG MGC132410

TUG MGC132410 can also be used as a biomarker to detect the recurrence and progression of various cancers. The expression level of TUG MGC132410 can be used as a good indicator of tumor recurrence because its expression level in tumor tissue usually increases with tumor recurrence. In addition, TUG MGC132410 can also be used as an important indicator of the progression of various cancers because it is positively correlated with survival time of tumor progression.

in conclusion

TUG MGC132410 is a drug target and biomarker with high pharmacological potential. TUG MGC132410 can inhibit the growth of various cancer cells and plays an important role in biological processes such as cell cycle, apoptosis and cell growth. Knockdown of TUG MGC132410 leads to the inhibition of growth and apoptosis of various cancer cells, thus having anti-tumor effects. In addition, TUG MGC132410 can also regulate the growth and apoptosis of various cancer cells, making it more lethal to tumor cells. TUG MGC132410 has good safety and tolerability and can serve as an important target for cancer treatment. TUG MGC132410 can also be used as a biomarker to detect the recurrence and progression of various cancers.

Protein Name: Tubulin Beta 6 Class V

Functions: Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin

The "TUBB6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TUBB6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets